| Year |
Citation |
Score |
| 2020 |
Hendricks AK, Zieminski JJ, Yao X, Dunlay SM, Sangaralingham LR, O'Meara JG, Herrin TR, Nei SD. Safety and Efficacy of Oral Anticoagulants for Atrial Fibrillation in Patients After Bariatric Surgery. The American Journal of Cardiology. PMID 32941819 DOI: 10.1016/J.Amjcard.2020.09.020 |
0.323 |
|
| 2020 |
Siontis KC, Yao X, Pirruccello JP, Philippakis AA, Noseworthy PA. How Will Machine Learning Inform the Clinical Care of Atrial Fibrillation? Circulation Research. 127: 155-169. PMID 32833571 DOI: 10.1161/Circresaha.120.316401 |
0.326 |
|
| 2020 |
Noseworthy PA, Attia ZI, Carter RE, Yao X, Friedman PA. An AI-ECG algorithm for atrial fibrillation risk: steps towards clinical implementation - Authors' reply. Lancet (London, England). 396: 236-237. PMID 32711795 DOI: 10.1016/S0140-6736(20)31064-3 |
0.327 |
|
| 2020 |
Kundi H, Noseworthy PA, Valsdottir LR, Shen C, Yao X, Yeh RW, Kramer DB. Relation of Frailty to Outcomes After Catheter Ablation of Atrial Fibrillation. The American Journal of Cardiology. PMID 32147090 DOI: 10.1016/J.Amjcard.2020.01.049 |
0.35 |
|
| 2020 |
Noseworthy PA, Van Houten HK, Gersh BJ, Packer DL, Friedman PA, Shah ND, Dunlay SM, Siontis KC, Piccini JP, Yao X. Generalizability of the CASTLE-AF Trial: Catheter Ablation for Patients with Atrial Fibrillation and Heart Failure in Routine Practice. Heart Rhythm. PMID 32145348 DOI: 10.1016/J.Hrthm.2020.02.030 |
0.365 |
|
| 2020 |
Siontis KC, Checkole S, Yao X, Gersh BJ, Noseworthy PA. Do Observational Studies Agree With Randomized Trials?: Evaluation of Oral Anticoagulants in Atrial Fibrillation. Journal of the American College of Cardiology. 75: 562-563. PMID 32029140 DOI: 10.1016/J.Jacc.2019.12.007 |
0.351 |
|
| 2020 |
Yao X, Noseworthy P. NOAC dosing and monitoring: really as simple as it seems? Heart (British Cardiac Society). PMID 31911506 DOI: 10.1136/Heartjnl-2019-316099 |
0.344 |
|
| 2019 |
Noseworthy PA, Kaufman ES, Chen LY, Chung MK, Elkind MSV, Joglar JA, Leal MA, McCabe PJ, Pokorney SD, Yao X. Subclinical and Device-Detected Atrial Fibrillation: Pondering the Knowledge Gap: A Scientific Statement From the American Heart Association. Circulation. CIR0000000000000740. PMID 31694402 DOI: 10.1161/Cir.0000000000000740 |
0.379 |
|
| 2019 |
Attia ZI, Noseworthy PA, Lopez-Jimenez F, Asirvatham SJ, Deshmukh AJ, Gersh BJ, Carter RE, Yao X, Rabinstein AA, Erickson BJ, Kapa S, Friedman PA. An artificial intelligence-enabled ECG algorithm for the identification of patients with atrial fibrillation during sinus rhythm: a retrospective analysis of outcome prediction. Lancet (London, England). PMID 31378392 DOI: 10.1016/S0140-6736(19)31721-0 |
0.361 |
|
| 2019 |
Abraham NS, Noseworthy PA, Inselman J, Herrin J, Yao X, Sangaralingham LR, Cornish G, Ngufor C, Shah ND. Risk Of Gastrointestinal Bleeding Increases With Combinations Of Antithrombotic Agents And Patient Age. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. PMID 31108228 DOI: 10.1016/J.Cgh.2019.05.017 |
0.341 |
|
| 2019 |
El-Harasis MA, DeSimone CV, Yao X, Noseworthy PA. Prediction and Management of Recurrences after Catheter Ablation in Atrial Fibrillation and Heart Failure. Cardiology Clinics. 37: 221-230. PMID 30926023 DOI: 10.1016/J.Ccl.2019.01.010 |
0.37 |
|
| 2019 |
Noseworthy PA, Gersh BJ, Kent DM, Piccini JP, Packer DL, Shah ND, Yao X. Atrial fibrillation ablation in practice: assessing CABANA generalizability. European Heart Journal. PMID 30875424 DOI: 10.1093/Eurheartj/Ehz085 |
0.329 |
|
| 2019 |
Yao X, Inselman JW, Shah ND, Ross JS, Izem R, Graham D, Martin D, Thompson A, Southworth MR, Siontis KC, Ngufor CG, Nath K, Desai NR, Nallamothu B, Saran R, et al. Abstract 11: Comparative Effectiveness and Safety of Oral Anticoagulants across Baseline Kidney Function Circulation: Cardiovascular Quality and Outcomes. 12. DOI: 10.1161/Hcq.12.Suppl_1.11 |
0.37 |
|
| 2019 |
Yao X, Shah N, Gersh B, Noseworthy P. Ten-Year Population Trends In Statin Therapy For Secondary Prevention: Use, Adherence, Cost, And Outcomes Journal of the American College of Cardiology. 73: 1734. DOI: 10.1016/S0735-1097(19)32340-X |
0.301 |
|
| 2018 |
Yao X, Gersh BJ, Lopez-Jimenez F, Shah ND, Noseworthy PA. Generalizability of the FOURIER trial to routine clinical care: Do trial participants represent patients in everyday practice? American Heart Journal. 209: 54-62. PMID 30685675 DOI: 10.1016/J.Ahj.2018.09.015 |
0.306 |
|
| 2018 |
Sabbag A, Yao X, Siontis KC, Noseworthy PA. Anticoagulation for Stroke Prevention in Older Adults with Atrial Fibrillation and Comorbidity: Current Evidence and Treatment Challenges. Korean Circulation Journal. 48: 873-889. PMID 30238705 DOI: 10.4070/Kcj.2018.0261 |
0.39 |
|
| 2018 |
Johnsrud DO, Melduni RM, Lahr B, Yao X, Greason KL, Noseworthy PA. Evaluation of Anticoagulation Use and Subsequent Stroke in Patients with Atrial Fibrillation after Empiric Surgical Left Atrial Appendage Closure: A Retrospective Case Control Study. Clinical Cardiology. PMID 30144129 DOI: 10.1002/Clc.23066 |
0.37 |
|
| 2018 |
Siontis KC, Zhang X, Eckard A, Bhave N, Schaubel DE, He K, Tilea A, Stack AG, Balkrishnan R, Yao X, Noseworthy PA, Shah ND, Saran R, Nallamothu BK. Outcomes Associated with Apixaban Use in End-Stage Kidney Disease Patients with Atrial Fibrillation in the United States. Circulation. PMID 29954737 DOI: 10.1161/Circulationaha.118.035418 |
0.379 |
|
| 2018 |
Yao X, Gersh BJ, Holmes DR, Melduni RM, Johnsrud DO, Sangaralingham LR, Shah ND, Noseworthy PA. Association of Surgical Left Atrial Appendage Occlusion With Subsequent Stroke and Mortality Among Patients Undergoing Cardiac Surgery. Jama. 319: 2116-2126. PMID 29800182 DOI: 10.1001/Jama.2018.6024 |
0.351 |
|
| 2018 |
Yao X, Gersh BJ, Sangaralingham LR, Shah ND, Noseworthy PA. Risk of cardiovascular events and incident atrial fibrillation in patients without prior atrial fibrillation: Implications for expanding the indications for anticoagulation. American Heart Journal. 199: 137-143. PMID 29754652 DOI: 10.1016/J.Ahj.2018.02.005 |
0.403 |
|
| 2018 |
Yao X, Noseworthy PA. To teach an old dog new tricks: The limits of CHADS-VASc in patients with atrial fibrillation and cancer. European Journal of Preventive Cardiology. 2047487318766942. PMID 29592530 DOI: 10.1177/2047487318766942 |
0.308 |
|
| 2018 |
Dembe AE, Yao X. 513 Why do female workers have a greater risk of long-term chronic disease compared to men? Occupational and Environmental Medicine. 75. DOI: 10.1136/Oemed-2018-Icohabstracts.1503 |
0.315 |
|
| 2018 |
Yao X, Gersh B, Sangaralingham L, Shah N, Noseworthy P. Do Compass Trial Participants Represent Patients In Everyday Practice Journal of the American College of Cardiology. 71. DOI: 10.1016/S0735-1097(18)30572-2 |
0.309 |
|
| 2017 |
Yao X, Shah ND, Sangaralingham LR, Gersh BJ, Noseworthy PA. Reply: NOAC Dosing in Patients With Atrial Fibrillation and Renal Dysfunction. Journal of the American College of Cardiology. 70: 2734-2735. PMID 29169488 DOI: 10.1016/J.Jacc.2017.09.1092 |
0.31 |
|
| 2017 |
Yao X, Tangri N, Gersh BJ, Sangaralingham LR, Shah ND, Nath KA, Noseworthy PA. Renal Outcomes in Anticoagulated Patients With Atrial Fibrillation. Journal of the American College of Cardiology. 70: 2621-2632. PMID 29169468 DOI: 10.1016/J.Jacc.2017.09.1087 |
0.374 |
|
| 2017 |
Noseworthy PA, Yao X, Gersh BJ, Hargraves I, Shah ND, Montori VM. Baseline characteristics and event rates among anticoagulated patients with atrial fibrillation in practice and pivotal NOAC trials. Data in Brief. 14: 563-565. PMID 28861455 DOI: 10.1016/J.Dib.2017.08.010 |
0.318 |
|
| 2017 |
Yao X, Gersh BJ, Sangaralingham LR, Kent DM, Shah ND, Abraham NS, Noseworthy PA. Comparison of the CHA2DS2-VASc, CHADS2, HAS-BLED, ORBIT, and ATRIA Risk Scores in Predicting Non-Vitamin K Antagonist Oral Anticoagulants-Associated Bleeding in Patients With Atrial Fibrillation. The American Journal of Cardiology. PMID 28844514 DOI: 10.1016/J.Amjcard.2017.07.051 |
0.38 |
|
| 2017 |
Noseworthy PA, Yao X, Gersh BJ, Hargraves I, Shah ND, Montori VM. Long-term stroke and bleeding risk in patients with atrial fibrillation treated with oral anticoagulants in contemporary practice: Providing evidence for shared decision-making. International Journal of Cardiology. PMID 28733071 DOI: 10.1016/J.Ijcard.2017.07.043 |
0.381 |
|
| 2017 |
Yao X, Shah ND, Sangaralingham LR, Gersh BJ, Noseworthy PA. Non-Vitamin K Antagonist Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Renal Dysfunction. Journal of the American College of Cardiology. 69: 2779-2790. PMID 28595692 DOI: 10.1016/J.Jacc.2017.03.600 |
0.362 |
|
| 2017 |
Noseworthy P, Yao X, Shah ND. P4019The impact of age on the effectiveness and safety of the NOACs versus warfarin for stroke prevention in atrial fibrillation European Heart Journal. 38. DOI: 10.1093/Eurheartj/Ehx504.P4019 |
0.327 |
|
| 2017 |
Noseworthy P, Yao X, Sangaralingham LR, Shah ND. 5716Age and gender differences in stroke and bleeding risks in atrial fibrillation patients treated with non-vitamin K antagonist oral anticoagulants European Heart Journal. 38. DOI: 10.1093/Eurheartj/Ehx493.5716 |
0.375 |
|
| 2017 |
Noseworthy P, Yao X, Tangri N, Shah N, Nath K. 5715Anticoagulant use and associated outcomes in patients with atrial fibrillation and advanced kidney disease European Heart Journal. 38. DOI: 10.1093/Eurheartj/Ehx493.5715 |
0.368 |
|
| 2017 |
Yao X, Tangri N, Sangaralingham L, Shah N, Noseworthy P. A Comparison Of Kidney Function Decline In Atrial Fibrillation Patients Treated With Non-Vitamin K Antagonist Oral Anticoagulants Or Warfarin Journal of the American College of Cardiology. 69: 2568. DOI: 10.1016/S0735-1097(17)35957-0 |
0.338 |
|
| 2016 |
Abraham NS, Noseworthy PA, Yao X, Sangaralingham LR, Shah ND. Gastrointestinal Safety of Direct Oral Anticoagulants: a Large Population-based Study. Gastroenterology. PMID 28043907 DOI: 10.1053/J.Gastro.2016.12.018 |
0.307 |
|
| 2016 |
Noseworthy PA, Yao X, Abraham NS, Sangaralingham LR, McBane RD, Shah ND. Direct Comparison of Dabigatran, Rivaroxaban, and Apixaban for Effectiveness and Safety in Nonvalvular Atrial Fibrillation. Chest. 150: 1302-1312. PMID 27938741 DOI: 10.1016/J.Chest.2016.07.013 |
0.372 |
|
| 2016 |
Yao X, Abraham NS, Sangaralingham LR, Bellolio MF, McBane RD, Shah ND, Noseworthy PA. Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation. Journal of the American Heart Association. 5. PMID 27412905 DOI: 10.1161/Jaha.116.003725 |
0.365 |
|
| 2016 |
Del-Carpio Munoz F, Yao X, Abraham NS, Bellolio MF, Rabinstein AA, Asirvatham SJ, McBane RD, Gersh BJ, Shah ND, Noseworthy PA. Dabigatran Versus Warfarin in Relation to Renal Function in Patients With Atrial Fibrillation. Journal of the American College of Cardiology. 68: 129-31. PMID 27364057 DOI: 10.1016/J.Jacc.2016.04.031 |
0.357 |
|
| 2016 |
Noseworthy PA, Yao X, Shah ND, Gersh BJ. Stroke and Bleeding Risks in NOAC- and Warfarin-Treated Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation. Journal of the American College of Cardiology. 67: 3020-1. PMID 27339501 DOI: 10.1016/J.Jacc.2016.04.026 |
0.387 |
|
| 2016 |
Dembe AE, Yao X. Chronic Disease Risks From Exposure to Long-Hour Work Schedules Over a 32-Year Period. Journal of Occupational and Environmental Medicine / American College of Occupational and Environmental Medicine. PMID 27305843 DOI: 10.1097/Jom.0000000000000810 |
0.629 |
|
| 2016 |
Madhavan M, Yao X, Sangaralingham LR, Asirvatham SJ, Friedman PA, McLeod CJ, Sugrue AM, DeSimone CV, Noseworthy PA. Ischemic Stroke or Systemic Embolism After Transseptal Ablation of Arrhythmias in Patients With Cardiac Implantable Electronic Devices. Journal of the American Heart Association. 5. PMID 27076562 DOI: 10.1161/Jaha.115.003163 |
0.35 |
|
| 2016 |
Yao X, Abraham NS, Alexander GC, Crown W, Montori VM, Sangaralingham LR, Gersh BJ, Shah ND, Noseworthy PA. Effect of Adherence to Oral Anticoagulants on Risk of Stroke and Major Bleeding Among Patients With Atrial Fibrillation. Journal of the American Heart Association. 5. PMID 26908412 DOI: 10.1161/Jaha.115.003074 |
0.39 |
|
| 2016 |
Noseworthy PA, Yao X, Shah ND, Gersh BJ. Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and valvular heart disease. International Journal of Cardiology. 209: 181-183. PMID 26896618 DOI: 10.1016/J.Ijcard.2016.02.005 |
0.37 |
|
| 2016 |
Al-Hijji MA, Deshmukh AJ, Yao X, Mwangi R, Sangaralingham LR, Friedman PA, Asirvatham SJ, Packer DL, Shah ND, Noseworthy PA. Trends and predictors of repeat catheter ablation for atrial fibrillation. American Heart Journal. 171: 48-55. PMID 26699600 DOI: 10.1016/J.Ahj.2015.10.015 |
0.342 |
|
| 2016 |
Yao X, Gersh B, Sangaralingham L, Shah N, Noseworthy P. The Performance Of The Has-Bled And Cha2D2-Vasc Scores In Predicting Major Bleeding Among Atrial Fibrillation Patients On Noacs Journal of the American College of Cardiology. 67: 667. DOI: 10.1016/S0735-1097(16)30668-4 |
0.337 |
|
| 2016 |
Yao X, Shah N, Sangaralingham L, Gersh B, Noseworthy P. Patterns and Predictors of Discontinuation and Switch in Atrial Fibrillation Patients Treated with Non-Vitamin K Antagonist Oral Anticoagulants Value in Health. 19. DOI: 10.1016/J.Jval.2016.03.162 |
0.327 |
|
| 2015 |
Noseworthy PA, Yao X, Deshmukh AJ, Van Houten H, Sangaralingham LR, Siontis KC, Piccini JP, Asirvatham SJ, Friedman PA, Packer DL, Gersh BJ, Shah ND. Patterns of Anticoagulation Use and Cardioembolic Risk After Catheter Ablation for Atrial Fibrillation. Journal of the American Heart Association. 4. PMID 26541393 DOI: 10.1161/Jaha.115.002597 |
0.39 |
|
| 2015 |
Yao X, Dembe AE, Wickizer T, Lu B. Does time pressure create barriers for people to receive preventive health services? Preventive Medicine. 74: 55-8. PMID 25773470 DOI: 10.1016/J.Ypmed.2015.03.008 |
0.593 |
|
| 2014 |
Dembe AE, Yao X, Wickizer TM, Shoben AB, Dong XS. Using O*NET to estimate the association between work exposures and chronic diseases. American Journal of Industrial Medicine. 57: 1022-31. PMID 24842122 DOI: 10.1002/Ajim.22342 |
0.617 |
|
| 2014 |
Dembe AE, Yao X, Wickizer TM, Shoben AB, Dong XS. A novel method for estimating the effects of job conditions on asthma and chronic lung disease. The Journal of Asthma : Official Journal of the Association For the Care of Asthma. 51: 799-807. PMID 24823324 DOI: 10.3109/02770903.2014.917183 |
0.619 |
|
| Show low-probability matches. |